A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alector, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 74,887 shares of ALEC stock, worth $192,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,887
Previous 68,166 9.86%
Holding current value
$192,459
Previous $309,000 12.94%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.34 - $6.58 $29,169 - $44,224
6,721 Added 9.86%
74,887 $349,000
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $285,615 - $424,674
68,166 New
68,166 $309,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $212M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.